(Incorporated in the Cayman Islands)

We are a pioneering provider of end-to-end innovative Hemp dosing solutions in the US that possesses the medical atomization and nebulizing background and sells nebulizers. We engage in the key activities in the Hemp cannabinoid E-vapors industry, including the research and development, formulation design, e-liquid production, e-liquid filling and e-liquid co-packing services. We believe our full-cycle operations and leading market position will position us to further capitalize on the growth potential of the US’ Hemp cannabinoid E-vapors market.

By leveraging our in-house innovative technology, strong manufacturing capabilities and deep-insight into end-users’ needs, we develop superior e-vapor products. We provide comprehensive innovative Hemp dosing solutions to companies in the Hemp and tobacco industries. Deeply involved in key activities including the formulation designing, the manufacturing and the final brand operating process at the same time, we are able to optimize production process based on designing, or can adjust the designing and manufacturing according to the market’s requirements in a timely manner. This synergy enables us to improve the efficiency of both formulation designing and production process and cover the limits of each other. In addition, our leading atomization technology, AiMesh® technology, significantly facilitates precise metering control, and our high-end aroma molecule blending technology, feelmixX® technology, perfectly combines traditional CBD oil with modern E-vapor oil, position us to provide broader applications across different sectors. Our Hemp cannabinoid E-vapors are marketed under the Cannapresso brand name, primarily on an Original Design Manufacturer (“ODM”) basis to other Hemp vapor companies. ODM generally involves the design and customization of the core products to meet a brand’s unique image and needs, and our products are sold by our customers under their own brand names although they may also include our brand name on the products.

Note: Net income and revenue are for the 12 months that ended March 31, 2025.